Critical temperature threshold measurement for cold urticaria: A randomized controlled trial of H 1-antihistamine dose escalation

British Journal of Dermatology

Volumn 166, Issue 5, 2012, Pages 1095-1099

  Magerl, M ^a   Pisarevskaja, D ^a   Staubach, P ^b   Martus, P ^a   Church, M K ^a   Maurer, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DESLORATADINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; COLD URTICARIA; CONTROLLED STUDY; CRITICAL TEMPERATURE THRESHOLD; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG EFFICACY; FATIGUE; FOREARM; HOSPITAL CARE; HUMAN; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE;

ADULT; AGED; COLD TEMPERATURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; LORATADINE; MIDDLE AGED; URTICARIA; YOUNG ADULT;

EID: 84860322157     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.10822.x     Document Type: Article

References (8)

1. Siebenhaar F, Staubach P, Metz M, et al. Peltier effect-based temperature challenge: an improved method for diagnosing cold urticaria. J Allergy Clin Immunol 2004; 114: 1224-5. (Pubitemid 39469169)
2. Siebenhaar F, Weller K, Mlynek A, et al. Acquired cold urticaria: clinical picture and update on diagnosis and treatment. Clin Exp Dermatol 2007; 32: 241-5. (Pubitemid 46495801)
3. Mlynek A, Magerl M, Siebenhaar F, et al. Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria. Br J Dermatol 2010; 162: 198-200.
4. Metz M, Scholz E, Ferran M, et al. Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. Ann Allergy Asthma Immunol 2010; 104: 86-92.
5. Siebenhaar F, Degener F, Zuberbier T, et al. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol 2009; 123: 672-9.
6. Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 2009; 64: 1427-43.
7. Geha RS, Meltzer EO,. Desloratadine: a new, nonsedating, oral antihistamine. J Allergy Clin Immunol 2001; 107: 751-62.
8. Kaplan AP, Beaven MA,. In vivo studies of the pathogenesis of cold urticaria, cholinergic urticaria, and vibration-induced swelling. J Invest Dermatol 1976; 67: 327-32.